Currently, there are 280.81M common shares owned by the public and among those 272.55M shares have been available to trade.
The company’s stock has a 5-day price change of -9.45% and -16.81% over the past three months. CLSK shares are trading 13.36% year to date (YTD), with the 12-month market performance up to 22.39% higher. It has a 12-month low price of $7.64 and touched a high of $24.72 over the same period. CLSK has an average intraday trading volume of 33.92 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.62%, -12.11%, and -22.33% respectively.
Institutional ownership of Cleanspark Inc (NASDAQ: CLSK) shares accounts for 41.29% of the company’s 280.81M shares outstanding.
It has a market capitalization of $2.93B and a beta (3y monthly) value of 4.25. The earnings-per-share (ttm) stands at -$0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.18% over the week and 8.24% over the month.
Analysts forecast that Cleanspark Inc (CLSK) will achieve an EPS of -0.16 for the current quarter, 0.04 for the next quarter and 0.45 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.26 while analysts give the company a high EPS estimate of -0.26. Comparatively, EPS for the current quarter was 0.15 a year ago. Earnings per share for the fiscal year are expected to increase by 177.93%, and 28.92% over the next financial year.
Looking at the support for the CLSK, a number of firms have released research notes about the stock. Keefe Bruyette stated their Outperform rating for the stock in a research note on January 27, 2025, with the firm’s price target at $19. JP Morgan coverage for the Cleanspark Inc (CLSK) stock in a research note released on December 10, 2024 offered a Overweight rating with a price target of $17. Macquarie was of a view on September 25, 2024 that the stock is Outperform, while JP Morgan gave the stock Neutral rating on December 08, 2023, issuing a price target of $9- $8. Bernstein on their part issued Outperform rating on October 31, 2023.
